AATK | Apoptosis-associated tyrosine kinase | | | | |
|
| Mitochondria | Tissue enhanced | 0 |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | | | | |
|
| Nucleoli Cytoplasm Golgi apparatus | Tissue enhanced | 0 |
AC006486.9 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000470087} | | | | | |
| | Tissue enhanced | 0 |
ACSBG1 | Acyl-CoA synthetase bubblegum family member 1 | | | | |
|
| | Tissue enhanced | 0 |
ADAM11 | ADAM metallopeptidase domain 11 | | | | | |
| Nucleus but not nucleoli | Tissue enhanced | 0 |
ADAM22 | ADAM metallopeptidase domain 22 | | | | |
|
| Nucleus Cytoskeleton (Intermediate filaments) | Tissue enhanced | 0 |
ADAM23 | ADAM metallopeptidase domain 23 | | | | |
|
| Cytoplasm Cytoskeleton (Microtubules) | Tissue enhanced | 0 |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | | | | |
|
| | Tissue enhanced | 0 |
ADCY2 | Adenylate cyclase 2 (brain) | | | | |
|
| Golgi apparatus Vesicles | Tissue enhanced | 0 |
ADORA1 | Adenosine A1 receptor | | | | | |
| Nucleoli | Tissue enhanced | 0 |
ADRA1B | Adrenoceptor alpha 1B | | | | | |
| | Tissue enhanced | 0 |
AGBL4 | ATP/GTP binding protein-like 4 | | | | |
|
| | Tissue enhanced | 0 |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | | | | |
|
| | Tissue enhanced | 0 |
AJAP1 | Adherens junctions associated protein 1 | | | | |
|
| | Tissue enhanced | 0 |
AKAP5 | A kinase (PRKA) anchor protein 5 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
AKAP6 | A kinase (PRKA) anchor protein 6 | | | | |
|
| | Tissue enhanced | 0 |
ALDOC | Aldolase C, fructose-bisphosphate | | | | |
|
| Nucleus Nucleoli Cytoplasm | Tissue enhanced | 0 |
ALK | Anaplastic lymphoma receptor tyrosine kinase | | | | |
|
| | Tissue enhanced | 0 |
AMZ1 | Archaelysin family metallopeptidase 1 | | | | |
|
| | Tissue enhanced | 0 |
ANK2 | Ankyrin 2, neuronal | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
ANLN | Anillin, actin binding protein | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
ANO3 | Anoctamin 3 | | | | |
|
| | Tissue enhanced | 0 |
APBA1 | Amyloid beta (A4) precursor protein-binding, family A, member 1 | | | | |
|
| | Tissue enhanced | 0 |
APBB3 | Amyloid beta (A4) precursor protein-binding, family B, member 3 | | | | |
|
| Cytoplasm Cytoskeleton (Actin filaments) | Tissue enhanced | 0 |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | |
| | Tissue enhanced | 0 |
ARHGEF4 | Rho guanine nucleotide exchange factor (GEF) 4 | | | | |
|
| | Tissue enhanced | 0 |
ASPHD1 | Aspartate beta-hydroxylase domain containing 1 | | | | |
|
| | Tissue enhanced | 0 |
ASTN1 | Astrotactin 1 | | | | | |
| | Tissue enhanced | 0 |
ATL1 | Atlastin GTPase 1 | | | | |
|
| | Tissue enhanced | 0 |
ATOH7 | Atonal homolog 7 (Drosophila) | | | | |
|
| | Tissue enhanced | 0 |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | | | | |
|
| | Tissue enhanced | 0 |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | | | | |
|
| | Tissue enhanced | 0 |
ATRNL1 | Attractin-like 1 | | | | | N/A |
| Nucleus Mitochondria | Tissue enhanced | 0 |
B3GALT1 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 | | | | |
|
| | Tissue enhanced | 0 |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | | | | | |
| Cytoplasm Nucleus Nucleoli | Tissue enhanced | 0 |
B3GNT4 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 | | | | |
|
| Mitochondria Nucleoli | Tissue enhanced | 0 |
B4GALNT4 | Beta-1,4-N-acetyl-galactosaminyl transferase 4 | | | | |
|
| Nucleus but not nucleoli Cytoskeleton (Microtubules) | Tissue enhanced | 0 |
BASP1 | Brain abundant, membrane attached signal protein 1 | | | | |
|
| Plasma membrane | Tissue enhanced | 0 |
BDNF | Brain-derived neurotrophic factor | | | | |
|
| | Tissue enhanced | 0 |
BEGAIN | Brain-enriched guanylate kinase-associated | | | | |
|
| Nucleus Cytoplasm Golgi apparatus | Tissue enhanced | 0 |
BEST3 | Bestrophin 3 | | | | |
|
| | Tissue enhanced | 0 |
BEX5 | Brain expressed, X-linked 5 | | | | |
|
| | Tissue enhanced | 0 |
BHLHE22 | Basic helix-loop-helix family, member e22 | | | | |
|
| | Tissue enhanced | 0 |
BRINP3 | Bone morphogenetic protein/retinoic acid inducible neural-specific 3 | | | | |
|
| | Tissue enhanced | 0 |
BRSK2 | BR serine/threonine kinase 2 | | | | | |
| | Tissue enhanced | 0 |
C15orf27 | Chromosome 15 open reading frame 27 | | | | |
|
| Plasma membrane Cytoplasm | Tissue enhanced | 0 |
C15orf59 | Chromosome 15 open reading frame 59 | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
C16orf45 | Chromosome 16 open reading frame 45 | | | | |
|
| Cytoplasm Nucleus but not nucleoli | Tissue enhanced | 0 |
C17orf96 | Chromosome 17 open reading frame 96 | | | | | N/A |
| Nucleus but not nucleoli | Tissue enhanced | 0 |
C19orf26 | Chromosome 19 open reading frame 26 | | | | | N/A |
| Nucleus but not nucleoli | Tissue enhanced | 0 |